GlobalRPh Renal Dosing Masterv6.6
GlobalRPh source record

Metronidazole

Flagyl

READ THE SOURCE-SPECIFIC ANSWER

Renal guidance at a glance

Confirm the product, indication and renal measure. The selected summary is not a complete prescribing monograph.

Choose a source to read (3)

Display order is not a clinical ranking. Date of retrieval is not the label revision date. Sources are never merged into one regimen. Other sources and conflicts remain below.

Rxlist source

GlobalRPh RX List - FLAGYL

Product / population
Oral metronidazole; selected renal-population guidance, not a dialysis schedule.
Renal measure
Mild/moderate impairment versus severe impairment or ESRD.

RX mirror: this is not independent corroboration of its underlying label. Check dated-label and formulation limitations.

Renal dosing, restrictions and evidence limits

No renal dose adjustment is stated for mild-to-moderate impairment. Metabolites may accumulate with severe impairment or ESRD in patients not receiving hemodialysis; monitor for metronidazole-related adverse effects. Dialysis timing and supplemental-dose decisions require the separate complete source sections and are not inferred from this paragraph.

Source revision: Source revision date not established in selected retrieval. | Retrieved: 2026-09-07. Retrieval date is not the revision date.

Source: https://globalrph.com/rx-list/flagyl-drug/

Scope: Selected source text imported locally; independent clinical review pending. Not a complete prescribing monograph. GlobalRPh v6.6.

Full source card / provenance

All sources, comparison tools and evidence navigation
Source-first renal review

Evidence sources and renal implications

Choose a source to jump directly to its locally stored result. Qualitative precautions and evidence gaps remain visible even when no numerical clearance schedule is supplied.

Preserved GlobalRPh source

Preserved original GlobalRPh source

Preserved historical content; not revalidated as current prescribing guidance.

Renal method: Read the measure and population stated in the original source sections.
Retrieved: 2026-09-05

GlobalRPh RX List

GlobalRPh RX List - FLAGYL

Qualified no-adjustment statement. Apply only to the population, product and renal range described in this source.

Oral metronidazole; selected renal-population guidance, not a dialysis schedule.

Renal method: Mild/moderate impairment versus severe impairment or ESRD.
Retrieved: 2026-09-07

Professional guidance

UCSF - metronidazole

Adults; source-specific institutional guidance. Match route, indication and renal replacement modality.

Renal method: CrCl in mL/min where specified; no equation inferred.
Retrieved: 2026-09-05

Source presence is not independent validation. A label mirror is not a second independent source; review the original reference and exact formulation.

Find text within this drug
Find a term without leaving this drug

Search the stored clinical text

Locate a word or phrase within this drug's source summaries. Choose all sources or one source to focus the search. The selection never hides warnings or source text, changes a dose, or proves that a renal finding is absent.

Find:

Enter at least two characters. Searches stay on this page and are not saved or sent.

All source summaries, original wording and provenance
Before applying a renal protocol

Check the setting. Compare whole sources.

No patient-specific dose is calculated. Context choices only display reminders; they do not validate, hide or change any regimen.

Share a reproducible source review

Choose sources below, then open a print-ready comparison with product scope, renal method, dates and cautions. Links can pin the exact local cards; they never contain patient values or choose a dose.

Open / share selected sources

Select two distinct source versions. The complete stored summaries will appear below.

Build a source-review outline for documentation

This creates a blank decision outline with the source identities you select, not a dose recommendation or completed clinical assessment. No patient fields are collected, saved or sent. Complete the clinical decisions in your approved documentation system.

Choose one or two sources above or use the source checkboxes below.

Renal-context checklist: population, kidney trend and dialysis

These prompts are a reading aid, not a prescription checklist or proof that all requirements have been met. No selections are stored or sent to a server.

Read the exact source scope, renal metric and date before selecting a row. No applicability assessment has been performed.

See source-specific renal methods and the clinical interpretation guide for the supporting context.

Go directly to the relevant source section

Renal dosing and precautions

Choose a source, then jump to its renal or dialysis section. These links locate stored text; they do not merge regimens or certify that sources agree.

New source summary - independent clinical review pending. Summaries of the identified label sections are included locally. Source import and numeric transcription checks are not independent two-reference validation. Do not treat this card as an approved institutional dosing protocol.

No dialysis or renal heading shown? Read the complete source summary. Absence of a heading is not evidence that dose adjustment is unnecessary.

Compare or copy source versions

All content below is stored locally. Read a whole source version; do not combine its dose with another source's interval, renal metric or dialysis assumptions.

Choose two source checkboxes below.
Historical source content is not a current prescription. Original GlobalRPh recommendations are preserved, not automatically certified as current. Product-label and professional additions below are separately attributed. Confirm indication, population, kidney-function method, monitoring and the full prescribing information before applying a regimen.

Important source distinctions

Historical trichomoniasis and pregnancy advice is not represented as current guideline-concordant treatment.

Locally stored source content

Original GlobalRPh protocol

Clinical facts and comments transcribed into a structured reading format. This is not a byte-for-byte HTML archive. Original source: https://globalrph.com/renal/metronidazole/

IV treatment and prophylaxis

Anaerobic infection: load 15 mg/kg IV over 1 hour (about 1 g at 70 kg), then 7.5 mg/kg over 1 hour every 6 hours (about 500 mg at 70 kg); begin maintenance 6 hours after starting the load. Convert to oral when severity/response allow. Maximum 4 g/day. Typical course 7-10 days; bone/joint, lower-respiratory or endocardial infection may need longer.

Severe hepatic disease causes slower metabolism and accumulation: cautiously reduce doses and monitor concentrations/toxicity. Continuous nasogastric suction may remove sufficient drug to lower serum concentrations. The source says not to reduce specifically for anuria because dialysis removes accumulated metabolites.

Colorectal surgical prophylaxis: 15 mg/kg over 30-60 minutes, completed about 1 hour before surgery, then 7.5 mg/kg over 30-60 minutes at 6 and 12 hours after the initial dose. Complete the preoperative dose before incision; give additional 6-hourly doses if needed to maintain concentrations. Limit prophylaxis to the day of surgery.

GRPH-metronidazole-01 · Source section: IV treatment and prophylaxisRenal section finder

Oral treatment and original comments

Older adults may have altered pharmacokinetics; concentration monitoring may guide adjustment.

Historical trichomoniasis regimens in women: 2 g in one day, either once or as two 1 g doses, or 250 mg three times daily for 7 days. The source discusses potentially higher cure rates with 7-day treatment, supervised single-dose adherence, protection against reinfection while partners are treated, and differing tolerability. Treatment in men is individualized similarly.

The original text advises against first-trimester treatment and against a one-day course in pregnant patients when alternative treatment has been inadequate, because of higher fetal exposure. These historical pregnancy statements are preserved as source content, not current clinical advice. For repeat courses it proposes waiting 4-6 weeks, reconfirming infection by laboratory testing, and obtaining total/differential leukocyte counts before and after retreatment.

Adult intestinal amebiasis: 750 mg orally three times daily for 5-10 days. Amebic liver abscess: 500 or 750 mg three times daily for 5-10 days. Pediatric amebiasis: 35-50 mg/kg/day in three doses for 10 days.

Serious anaerobic infection usually begins with IV therapy; oral dosing is 7.5 mg/kg every 6 hours, maximum 4 g/day, usually 7-10 days. The same hepatic and anuria comments apply.

GRPH-metronidazole-02 · Source section: Oral treatment and original commentsRenal section finder

Renal Dosing and source differences

CrCl above 10 mL/min: no change. Below 10 without dialysis, the source explicitly lists different recommendations: no change at any impairment level (single-dose pharmacokinetics unchanged and dialysis removes metabolites), versus 50% of the usual dose at the same interval or 500 mg every 12 hours.

The GlobalRPh conclusion favors no routine reduction or interval extension based on the manufacturer discussion and pharmacokinetics. Both the alternative and the conclusion are retained rather than blended.

GRPH-metronidazole-03 · Source section: Renal Dosing and source differencesRenal section finder

Hemodialysis and continuous therapy

Extensive hemodialysis removal: schedule the conventional dose after dialysis on dialysis days. Continuous arteriovenous or venovenous hemofiltration: dose as for normal renal function in the source.

GRPH-metronidazole-04 · Source section: Hemodialysis and continuous therapyRenal section finder
Locally imported selected renal sections

GlobalRPh RX List renal information

Rxlist

GlobalRPh RX List - FLAGYL

Open original reference

Open / share this exact local source

GlobalRPh-hosted RX List · Oral metronidazole; selected renal-population guidance, not a dialysis schedule.

Renal method: Mild/moderate impairment versus severe impairment or ESRD.
Source date: Source revision date not established in selected retrieval.
Retrieved: 2026-09-07

Label mirror, not independent corroboration. This is selected locally stored RX List content. Full monograph import and current official-label review are not implied.
Qualified no-adjustment statement. Apply only to the population, product and renal range described in this source.

Selected source text imported locally; independent clinical review pending. Not a complete prescribing monograph.

Renal dosing, restrictions and evidence limits

No renal dose adjustment is stated for mild-to-moderate impairment. Metabolites may accumulate with severe impairment or ESRD in patients not receiving hemodialysis; monitor for metronidazole-related adverse effects. Dialysis timing and supplemental-dose decisions require the separate complete source sections and are not inferred from this paragraph.

RDM41-rxlist-metronidazole-9f2eaba68f-C1 · Source locator: Dosage / Use in specific populations: renal impairment

Source identity and provenance
Source family
product_label_mirror
Source
https://globalrph.com/rx-list/flagyl-drug/
Retrieved
2026-09-07
Renal-function method
Mild/moderate impairment versus severe impairment or ESRD.
Source date/version
Source revision date not established in selected retrieval.
Hash meaning
SHA-256 of local authored summary only; not original HTML, PDF or SPL bytes.
Local summary SHA-256
dcf30f6739c76fde2ecf50506a41d507f03abcd0c6f448a10af6edc32c826db3
Separate professional-source layer

University and professional protocols

Professional

UCSF - metronidazole

Open original reference

Open / share this exact local source

UCSF Infectious Diseases Management Program · Adults; source-specific institutional guidance. Match route, indication and renal replacement modality.

Renal method: CrCl in mL/min where specified; no equation inferred.
Source date: Revision date not stated in the reviewed page.
Retrieved: 2026-09-05

Locally included source-specific summary. Regimen differences are not automatically resolved.

Dosing / renal protocol and limits

The standard adult systemic regimen is 500 mg IV/orally every 8 hours when CrCl >10 mL/min and every 12 hours below 10. Exactly 10 is omitted in the displayed bands.

For bacterial vaginosis, vaginal trichomoniasis or intra-abdominal infection other than C. difficile, 500 mg every 12 hours is retained in both renal columns. During either IHD or CVVHD, the standard regimen is 500 mg every 8 hours; the listed indication-specific every-12-hour regimens remain every 12 hours. Do not infer dialysis dosing from the non-dialysis low-clearance row.

RDM30-019-metronidazole-1 · Source locator: UCSF - metronidazole; renal/dosing sections and stated qualifiers

Source identity and provenance
Source
https://idmp.ucsf.edu/content/metronidazole
Retrieved
2026-09-05
Renal-function method
CrCl in mL/min where specified; no equation inferred.
Source date/version
Revision date not stated in the reviewed page.
Hash meaning
Locally authored summary text; not original SPL, HTML or PDF bytes
Local summary SHA-256
7392440c506cced7e60cef78a6356636c70b97941379d0e2f26ee8691dc260ee

Provenance and preservation

Additional summaries stored on this page: 0 official-label, 1 RX List, 1 professional, 0 handbook. Empty additional-source groups are not shown. A missing layer is not a no-adjustment recommendation.

Original source
https://globalrph.com/renal/metronidazole/
Source retrieval
2026-09-05. This is not the source publication or label revision date.
Original source type
globalrph individual
Local text SHA-256
0ca2f546977aa5a02605fd62db9449f725fb6c8b139339f805e542a5a68ae8e1
Import versus clinical validation
Source-section locators identify where retained content came from. A source-section identifier does not assert that every numeric statement has been independently corroborated. The local text hash is not a hash of original HTML, an FDA PDF or SPL XML.

The original individual GlobalRPh pages commonly cite NIH/NLM DailyMed and instruct readers to review the applicable package insert for updates. That historical reference is preserved as context; it is not counted as an independently retrieved current label.

Read the full coverage report